Suppr超能文献

miR-26a的表达与HMGA1呈负相关,并通过靶向HMGA1调控肺腺癌细胞的癌症进展。

Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.

作者信息

Sekimoto Noboru, Suzuki Ayako, Suzuki Yutaka, Sugano Sumio

机构信息

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo 108‑8639, Japan.

Division of Translational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277‑8577, Japan.

出版信息

Mol Med Rep. 2017 Feb;15(2):534-542. doi: 10.3892/mmr.2016.6053. Epub 2016 Dec 15.

Abstract

Lung cancer is the most common cause of cancer‑associated mortality worldwide, and the number of cases is increasing annually. Several studies have shown that microRNAs (miRNAs) control proliferation, differentiation, and apoptosis in various cell types, and increasing evidence indicates the presence of aberrant miRNA expression profiles and unique miRNA signaling pathways in several types of cancer. The present study aimed to identify miRNAs, which correlated specifically with the progression of lung cancer through the analysis of 57,100 transcripts and 1,341 small RNA expression profiles in 26 lung adenocarcinoma cell lines using next‑generation sequencing. The most marked negative correlation was found between the expression of hsa‑miR‑26a‑1 and messenger RNA (mRNA), and a list of mRNAs, which exhibited negative correlation with hsa‑miR‑26a‑1 were investigated. The most marked negative correlation was observed between the expression levels of hsa‑miR‑26a‑1 and high mobility group A1 (HMGA1). Using a lung adenocarcinoma cell line, the present study analyzed the effect of the overexpression of miR‑26a on the expression of HMGA1 and found that miR‑26a repressed the expression of HMGA1 by reducing the mRNA levels of HMGA1. Furthermore, it was demonstrated that the overexpression of miR‑26a in a lung adenocarcinoma cell line repressed cell migration, invasion and growth by targeting HMGA1. Taken together, the present study showed a significant negative correlation between the expression of miR‑26a and HMGA1 in 26 lung adenocarcinoma cell lines, and provided evidence that the suppression of miR‑26a supports the progression of cancer by stimulating the expression of HMGA1.

摘要

肺癌是全球癌症相关死亡的最常见原因,且病例数每年都在增加。多项研究表明,微小RNA(miRNA)可控制多种细胞类型的增殖、分化和凋亡,越来越多的证据表明,在几种类型的癌症中存在异常的miRNA表达谱和独特的miRNA信号通路。本研究旨在通过使用下一代测序分析26种肺腺癌细胞系中的57,100个转录本和1,341个小RNA表达谱,来鉴定与肺癌进展特异性相关的miRNA。在hsa-miR-26a-1的表达与信使核糖核酸(mRNA)之间发现了最显著的负相关,并对与hsa-miR-26a-1呈负相关的mRNA列表进行了研究。在hsa-miR-26a-1与高迁移率族蛋白A1(HMGA1)的表达水平之间观察到最显著的负相关。本研究使用一种肺腺癌细胞系,分析了miR-26a过表达对HMGA1表达的影响,发现miR-26a通过降低HMGA1的mRNA水平来抑制HMGA1的表达。此外,还证明了在肺腺癌细胞系中miR-26a的过表达通过靶向HMGA1来抑制细胞迁移、侵袭和生长。综上所述,本研究表明在26种肺腺癌细胞系中miR-26a与HMGA1的表达之间存在显著负相关,并提供了证据表明miR-26a的抑制通过刺激HMGA1的表达来支持癌症进展。

相似文献

3
High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Mol Cell Biochem. 2011 Nov;357(1-2):363-71. doi: 10.1007/s11010-011-0907-1. Epub 2011 Jun 9.
4
HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy.
Biochemistry (Mosc). 2014 Jun;79(6):538-44. doi: 10.1134/S0006297914060078.
5
IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
Oncotarget. 2016 Oct 25;7(43):70247-70263. doi: 10.18632/oncotarget.11838.
7
Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
Mol Cancer Res. 2009 Nov;7(11):1803-12. doi: 10.1158/1541-7786.MCR-08-0336. Epub 2009 Nov 10.
8
MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3771-3778. doi: 10.26355/eurrev_201905_17803.
9
miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Cell Biochem Funct. 2017 Oct;35(7):464-471. doi: 10.1002/cbf.3304. Epub 2017 Oct 10.
10
MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Gastroenterology. 2013 Mar;144(3):624-635.e4. doi: 10.1053/j.gastro.2012.11.033. Epub 2012 Nov 27.

引用本文的文献

1
Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer.
Cancer Cell Int. 2025 Mar 7;25(1):80. doi: 10.1186/s12935-025-03713-1.
2
The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma.
Open Med (Wars). 2024 Aug 10;19(1):20240974. doi: 10.1515/med-2024-0974. eCollection 2024.
3
MicroRNA-26a in respiratory diseases: mechanisms and therapeutic potential.
Mol Biol Rep. 2024 May 8;51(1):627. doi: 10.1007/s11033-024-09576-5.
4
circ-LIMK1 regulates cisplatin resistance in lung adenocarcinoma by targeting miR-512-5p/HMGA1 axis.
Open Med (Wars). 2022 Oct 7;17(1):1568-1583. doi: 10.1515/med-2022-0542. eCollection 2022.
5
Prognostic Significance of Expression in Lung Cancer Based on Bioinformatics Analysis.
Int J Mol Sci. 2022 Jun 22;23(13):6933. doi: 10.3390/ijms23136933.
6
Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis.
Bioengineered. 2021 Dec;12(1):1212-1225. doi: 10.1080/21655979.2021.1907128.
7
HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis.
Cancer Manag Res. 2021 Jan 27;13:787-794. doi: 10.2147/CMAR.S289997. eCollection 2021.
9
HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
Int J Mol Sci. 2020 Apr 24;21(8):3014. doi: 10.3390/ijms21083014.
10
High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network.
Int J Mol Sci. 2020 Jan 22;21(3):717. doi: 10.3390/ijms21030717.

本文引用的文献

1
RNA-Mediated Regulation of HMGA1 Function.
Biomolecules. 2015;5(2):943-57. doi: 10.3390/biom5020943.
2
MicroRNA and pediatric tumors: Future perspectives.
Acta Histochem. 2015 May-Jun;117(4-5):339-54. doi: 10.1016/j.acthis.2015.02.007. Epub 2015 Mar 9.
3
MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Int J Clin Exp Pathol. 2015 Jan 1;8(1):368-73. eCollection 2015.
4
Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis.
Genes Dev. 2014 Dec 1;28(23):2585-90. doi: 10.1101/gad.250951.114. Epub 2014 Nov 13.
5
Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.
Nucleic Acids Res. 2014 Dec 16;42(22):13557-72. doi: 10.1093/nar/gku885. Epub 2014 Nov 6.
6
MiR-26a inhibits prostate cancer progression by repression of Wnt5a.
Tumour Biol. 2014 Oct;35(10):9725-33. doi: 10.1007/s13277-014-2206-4. Epub 2014 Jun 28.
7
miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
FEBS Lett. 2013 Aug 2;587(15):2467-73. doi: 10.1016/j.febslet.2013.06.021. Epub 2013 Jun 22.
8
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
Biochim Biophys Acta. 2012 Nov;1822(11):1692-704. doi: 10.1016/j.bbadis.2012.07.019. Epub 2012 Aug 4.
9
Epigenetic biomarkers in lung cancer.
Cancer Lett. 2014 Jan 28;342(2):200-12. doi: 10.1016/j.canlet.2012.04.018. Epub 2012 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验